Cargando…
Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives
A new series of pyrazolo[3,4-d]pyrimidines has been synthesized. The new compounds were tested for their antitumor activity on 60 different cell lines, and some of the compounds were found to have potent antitumor activity. In particular, 2-hydroxybenzaldehyde [1-(4-chlorophenyl)-3-methyl-1H-pyrazol...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447607/ https://www.ncbi.nlm.nih.gov/pubmed/23008804 http://dx.doi.org/10.3797/scipharm.1204-23 |
_version_ | 1782244124382986240 |
---|---|
author | Kandeel, Manal M. Mohamed, Lamia W. Abd El Hamid, Mohammed K. Negmeldin, Ahmed T. |
author_facet | Kandeel, Manal M. Mohamed, Lamia W. Abd El Hamid, Mohammed K. Negmeldin, Ahmed T. |
author_sort | Kandeel, Manal M. |
collection | PubMed |
description | A new series of pyrazolo[3,4-d]pyrimidines has been synthesized. The new compounds were tested for their antitumor activity on 60 different cell lines, and some of the compounds were found to have potent antitumor activity. In particular, 2-hydroxybenzaldehyde [1-(4-chlorophenyl)-3-methyl-1H-pyrazolo-[3,4-d]pyrimidin-4-yl]hydrazone (VIIa) was found to be the most effective among the other derivatives, showing IC50 values of 0.326 to 4.31 μM on 57 different cell lines. |
format | Online Article Text |
id | pubmed-3447607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Österreichische Apotheker-Verlagsgesellschaft |
record_format | MEDLINE/PubMed |
spelling | pubmed-34476072012-09-24 Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives Kandeel, Manal M. Mohamed, Lamia W. Abd El Hamid, Mohammed K. Negmeldin, Ahmed T. Sci Pharm Research Article A new series of pyrazolo[3,4-d]pyrimidines has been synthesized. The new compounds were tested for their antitumor activity on 60 different cell lines, and some of the compounds were found to have potent antitumor activity. In particular, 2-hydroxybenzaldehyde [1-(4-chlorophenyl)-3-methyl-1H-pyrazolo-[3,4-d]pyrimidin-4-yl]hydrazone (VIIa) was found to be the most effective among the other derivatives, showing IC50 values of 0.326 to 4.31 μM on 57 different cell lines. Österreichische Apotheker-Verlagsgesellschaft 2012 2012-06-25 /pmc/articles/PMC3447607/ /pubmed/23008804 http://dx.doi.org/10.3797/scipharm.1204-23 Text en © Kandeel et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kandeel, Manal M. Mohamed, Lamia W. Abd El Hamid, Mohammed K. Negmeldin, Ahmed T. Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives |
title | Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives |
title_full | Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives |
title_fullStr | Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives |
title_full_unstemmed | Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives |
title_short | Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives |
title_sort | design, synthesis, and antitumor evaluation of novel pyrazolo[3,4-d]pyrimidine derivatives |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447607/ https://www.ncbi.nlm.nih.gov/pubmed/23008804 http://dx.doi.org/10.3797/scipharm.1204-23 |
work_keys_str_mv | AT kandeelmanalm designsynthesisandantitumorevaluationofnovelpyrazolo34dpyrimidinederivatives AT mohamedlamiaw designsynthesisandantitumorevaluationofnovelpyrazolo34dpyrimidinederivatives AT abdelhamidmohammedk designsynthesisandantitumorevaluationofnovelpyrazolo34dpyrimidinederivatives AT negmeldinahmedt designsynthesisandantitumorevaluationofnovelpyrazolo34dpyrimidinederivatives |